-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Foslinanib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Foslinanib in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Foslinanib in Solid Tumor Drug Details:Foslinanib (TRX-818) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Estradiol + Progesterone) in Genitourinary Syndrome of Menopause (GSM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Estradiol + Progesterone) in Genitourinary Syndrome of Menopause (GSM)Drug Details:Estradiol in combination with progesterone is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elsulfavirine in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elsulfavirine in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Elsulfavirine in Human Immunodeficiency Virus (HIV) Infections (AIDS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cyclosam in Osteosarcoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cyclosam in Osteosarcoma Drug Details: Cyclosam is under development for the treatment of osteosarcoma, Ewing...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GD2-SADA in Small-Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GD2-SADA in Small-Cell Lung Cancer Drug Details:Monoclonal antibody conjugate is under development for the treatment of...
-
Product Insights
Dobrinskoye and VM (Vostochny Makarovskoye) Field, Russia
Dobrinskoye and VM (Vostochny Makarovskoye) Field is a producing field located in Volgograd Oblast, Russia. It is being operated by Gaznefteservis. Empower your strategies with our Dobrinskoye and VM (Vostochny Makarovskoye) Field, Russia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
Mitre Realty – Raizes VM Residential Complex – Sao Paulo
Equip yourself with the essential tools needed to make informed and profitable decisions with our Mitre Realty - Raizes VM Residential Complex - Sao Paulo report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Chile Still Wine market dynamics
Empower your strategies with our Chile Still Wine market dynamics report and make more profitable business decisions. Consumers' preferences for wines and spirits are most heavily influenced by novel flavors, premium ingredients, product prices, and packaging. However, manufacturers continue to launch and sell products based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Wines and spirits manufacturers can benefit from the unique intelligence provided by the GlobalData Consumer Intelligence platform, covering more than 2 million products...
-
Company Profile
Aqua Security Software Ltd – Company Profile
Aqua Security Software Ltd (Aqua) is a provider of the container security platform. The company provides native security platform, CSPM cloud security, container security, kubernetes security, serverless security, cloud VM security, dynamic threat analysis (DTA), vulnerability scanning, open source container security and platform integrations. Aqua also provides automated security for development and operations (DevOps), cloud native detection and response, modern container security for native apps, regulatory compliance, and hybrid cloud and multi cloud architecture. The company operates in the US,...
Add to Basket -
Company Profile
Varian Medical Systems Inc – Company Profile
Varian Medical Systems Inc (VMS) designs, manufactures, and sells medical devices, associated hardware and software, and a broad portfolio of interventional solutions for the treatment of cancer. The company’s major product areas include radiosurgery, radiotherapy, proton therapy, brachytherapy, adaptive therapy, interventional therapy, and software. VMS markets its products to private and government institutions, university research and community hospitals, oncology practices, healthcare agencies, physicians’ offices, radiotherapy centers, and cancer care clinics in North America, Europe, Asia-Pacific, the Middle East, and Africa....
Add to Basket